+1-310-284-6113

Emily J. Cook

Partner
McDermott Will & Emery
Los Angeles

Practice Area: Regulatory

    All-Star

    ALL-STAR BIOGRAPHY

    Emily Jane Cook advises healthcare providers on complex regulatory and reimbursement matters, enabling them to evaluate and mitigate the compliance risks of new business initiatives and existing service lines. As a widely-recognized national authority on the 340B drug pricing program, Emily counsels healthcare providers and other stakeholders on issues related to implementation, compliance and advocacy. With her extensive regulatory experience, she effectively and efficiently provides guidance to clients on a wide range of key concerns, such as fee-for-service Medicare and Medicaid reimbursement, billing and coding, licensure, survey/certification and accreditation, and compliance with Medicare and state fraud and abuse requirements. She also advises clients facing government audits, whistleblowers actions, and self-disclosures, working to preserve their government program participation and reduce or eliminate government program refunds and administrative penalties.

    Visit All-Star's Firm »


    +1-310-284-6113

    Emily J. Cook

    Partner
    McDermott Will & Emery
    Los Angeles

    Practice Area: Regulatory

    M&A All-Star

    WHAT CLIENTS SAY

    "Emily understands what we need in the regulatory area."
    "Emily has a superior understanding of our business and our needs."


    MY CLIENT PHILOSOPHY

    "My job is to navigate our clients’ complex regulatory challenges and develop workable solutions. For every question that comes in, it is essential think about why our client has engaged us to help them, how they will be using the guidance we provide and how best to provide our services to meet their specific needs. Every client and every project is different- there is no “one size fits all” approach."

    – Emily J. Cook

    ALL-STAR BIOGRAPHY

    Emily Jane Cook advises healthcare providers on complex regulatory and reimbursement matters, enabling them to evaluate and mitigate the compliance risks of new business initiatives and existing service lines. As a widely-recognized national authority on the 340B drug pricing program, Emily counsels healthcare providers and other stakeholders on issues related to implementation, compliance and advocacy. With her extensive regulatory experience, she effectively and efficiently provides guidance to clients on a wide range of key concerns, such as fee-for-service Medicare and Medicaid reimbursement, billing and coding, licensure, survey/certification and accreditation, and compliance with Medicare and state fraud and abuse requirements. She also advises clients facing government audits, whistleblowers actions, and self-disclosures, working to preserve their government program participation and reduce or eliminate government program refunds and administrative penalties.

    Visit All-Star's Firm »